Bryn Mawr Trust Advisors LLC decreased its holdings in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 2.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 124,401 shares of the company’s stock after selling 3,436 shares during the quarter. Procter & Gamble makes up about 0.9% of Bryn Mawr Trust Advisors LLC’s investment portfolio, making the stock its 28th largest position. Bryn Mawr Trust Advisors LLC’s holdings in Procter & Gamble were worth $17,969,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in the business. E Fund Management Hong Kong Co. Ltd. raised its holdings in shares of Procter & Gamble by 1,000.0% in the fourth quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company’s stock valued at $25,000 after buying an additional 150 shares during the last quarter. Litman Gregory Wealth Management LLC bought a new stake in Procter & Gamble during the 4th quarter worth about $26,000. Park Square Financial Group LLC grew its holdings in Procter & Gamble by 65.1% during the 4th quarter. Park Square Financial Group LLC now owns 180 shares of the company’s stock worth $26,000 after acquiring an additional 71 shares during the last quarter. Evolution Wealth Management Inc. increased its position in Procter & Gamble by 1,315.4% in the 4th quarter. Evolution Wealth Management Inc. now owns 184 shares of the company’s stock valued at $26,000 after acquiring an additional 171 shares in the last quarter. Finally, Basso Capital Management L.P. acquired a new stake in Procter & Gamble in the 4th quarter valued at about $28,000. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Up 0.9%
Shares of NYSE:PG opened at $148.41 on Tuesday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53. The stock has a market cap of $345.59 billion, a price-to-earnings ratio of 21.70, a P/E/G ratio of 6.26 and a beta of 0.39. The company has a 50 day moving average of $146.60 and a 200-day moving average of $148.44. Procter & Gamble Company has a one year low of $137.62 and a one year high of $167.25.
Analyst Ratings Changes
PG has been the topic of a number of research reports. Royal Bank Of Canada reduced their target price on shares of Procter & Gamble from $172.00 to $167.00 and set an “outperform” rating on the stock in a research report on Thursday, April 9th. Jefferies Financial Group raised their price target on shares of Procter & Gamble from $177.00 to $179.00 and gave the company a “buy” rating in a report on Friday, June 26th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $163.00 price objective on shares of Procter & Gamble in a research report on Monday, April 27th. TD Cowen increased their price objective on Procter & Gamble from $142.00 to $150.00 and gave the company a “hold” rating in a research report on Monday, April 27th. Finally, Barclays lowered their target price on Procter & Gamble from $155.00 to $146.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 14th. Twelve equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $161.42.
View Our Latest Stock Report on PG
Procter & Gamble Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More
- Five stocks we like better than Procter & Gamble
- The SK Hynix IPO and 2027’s AI Memory Squeeze
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
